J Pharm Pharmacogn Res 3(suppl. 1): S189, 2015
Proceedings of the 4th International Symposium on Pharmacology of Natural Products FAPRONATURA 2015 September 21st-25th, 2015; Cuban Society of Pharmacology. Topes de Collantes, Sancti Spiritus, Cuba.
POS-96: EVALUATION OF ANTIFUNGAL ACTIVITY OF HOMOEOPATHIC MEDICINES AGAINST HUMAN PATHOGENIC FUNGI Candida albicans in-vitro MODEL
Gupta P1, Sundaram EN1, Dwivedi B1, Changani S1, Kaur H2, Nayak D2, Khurana A2, Manchanda R2.
Objective: The objective of the present study was to evaluate in-vitro antifungal activity of homoeopathic medicines on the growth of human pathogenic fungi Candida albicans. Methods: Homoeopathic medicines (ф, 3x, 6x & 12x) of Allium sativum, Allium cepa, Ocimum sanctum and Ficus religiosa were tested against the growth of human pathogenic fungi Candida albicans obtained from MTCC, Institute of Microbial Technology; Chandigarh by using paper disc method. The diameters of inhibition zones (mm) were measured and the results so obtained were compared with that of the control. Ketoconazole was used as reference standard fungicide. Results: The results indicates that mother tinctures (both water and alcohol based), 6x of A. sativum; mother tincture (alcohol based), 6x, 12x of A. cepa; 6x, 12x of O. sanctum and 12x of F. religiosa showed inhibition zones against the growth of C. albicans as compared to control. Out of all the four medicines tested, A. sativum showed maximum zone of inhibition as compared to A. cepa, O. sanctum and F. religiosa. Conclusions: The present study suggests that these homoeopathic medicines possess in-vitro antifungal effect against human pathogenic fungi C. albicans.
Citation Format: Gupta P, Sundaram EN, Dwivedi B, Changani S, Kaur H, Nayak D, Khurana A, Manchanda R (2015) Evaluation of antifungal activity of homoeopathic medicines against human pathogenic fungi Candida albicans in-vitro model. [Abstract]. In: Proceedings of the FAPRONATURA 2015; 2015 Sep 21-25; Topes de Collantes, Sancti Spiritus: CSF. J Pharm Pharmacogn Res 3(Suppl. 1): S189. Abstract nr POS-96.